Abdominal Migraine
BMJ 360;k179, Angus-Leppan, H.,et al, 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
Acetazolamide Treatment for Migraine Aura Status
Neurol 55:1588-1589, Haan,J.,et al, 2000
Safety and Efficacy of Ergotamine Tartrate & Dihydroergotamine in the Trmt of Migraine & Status Migrainosus
Neurol 45:577-584, Silberstein,S.D.,et al, 1995
Practice Parameter:Appropriate Use of Ergotamine Tartrate & Dihydroergotamine in the Trmt of Migraine & Status Migrainosus
Neurol 45:585-587, , 1995
Anticonvulsant Drugs for Management of Pain:A Systematic Review
BMJ 311:1047-1052, McQuay,H.,et al, 1995
Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992
Randomized Double-Blind Trial of Intravenous Prochlorperazine for the Treatment of Acute Headache
JAMA 261:1174-1176, Jones,J.,et al, 1989
Possible Benefit of GR43175, A Novel 5-HT1-Like Receptor Agonist for the Acute Treatment of Severe Migraine
Lancet 1:1309-1311, Doenicke,A.,et al, 1988
Repetitive Intravenous Dihydroergotamine as Therapy for Intractable Migraine
Neurol 36:995-997, Raskin,N.H., 1986